Your search returned 13 results.

Sort
Results
1.
Guidelines for the indications for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_161
2.
Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_235
3.
Guidelines for the prescribed activity for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_236
4.
Guidelines for the prescribed activity for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_162
5.
124 I-Nal PET/CT Based 3-D radiobiological dosimetry (3D-RD) for 131I-Nal therapy of metastatic well-differentiated thyroid cancer. MedStar authors:
  • Atkins, Frank
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Senthamizhchelvan S, Hobbs R, Atkins F, Khorjekar G, Orquiza M, Van Nostrand D, Sgouros G
Local accession number:
  • 2013_166
6.
#Alpharadinr #(Xofigor) in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors:
  • Duong, Eric
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Duong E, Orquiza M, Khorjekar G, Van Nostrand D
Local accession number:
  • 2013_159
7.
Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors:
  • Duong, Eric
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Duong E, Orquiza M, Khorjekar G, Van Nostrand D
Local accession number:
  • 2013_233
8.
A comparison of the frequency, duration and severity of salivary side effects in differentiated thyroid cancer patients treated with <1.85 Gbq (50 Mci) Versus >7.4 Gbq (200 Mci) I-131 therapy: an analysis of the ThyCa National Survey. MedStar authors:
  • Brennan, Michael T
  • Hall, Jordan
  • Khorjekar, Gauri
  • Van Nostrand, Douglas
  • Wu, Di
  • Zeymo, Alexander
Year: 2017
Citation:
  • Unpublished 2017/10/03
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bloom G
  • Brennan MT
  • Hall J
  • Khorjekar G
  • McIver B
  • Van Nostrand D
  • Wu D
  • Zeymo A
Local accession number:
  • A2017_050
9.
Characterization of sialoadenitis after administration of continous sialogogues during the day and night After 131 I therapy. MedStar authors:
  • Acio, Elmo
  • Burman, Kenneth D
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Kulkarni, Kanchan
  • Orquiza, Michael D
  • Schneider, Mark
  • Wartofsky, Leonard
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Endocrinology
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L
Local accession number:
  • 2013_165
10.
Survival rate in differentiated thyroid cancer patients with bone metastases. MedStar authors:
  • Atkins, Francis
  • Burman, Kenneth D
  • Khorjekar, Gauri R
  • Kulkarni, Kanchan
  • Moreau, Shari
  • Orquiza, Michael H
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Department:
  • Medicine/Endocrinology
  • Medicine/General Internal Medicine
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Orquiza M, Van Nostrand D, Khorjekar G, Moreau S, Atkins F, Kulkarni K, Burman KD, Wartofsky L
Local accession number:
  • 2014.1_132
11.
Characterization of Sialoadenitis (SA) after administration of continuous Sialogogues (SGs) during the day and night after 131I therapy (tx). MedStar authors:
  • Acio, Elmo
  • Burman, Kenneth D
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Kulkarni, Kanchan
  • Orquiza, Michael D
  • Schneider, Mark
  • Wartofsky, Leonard
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
Local accession number:
  • 2013_230
12.
Epiphora and xerophthalmia after 131I therapy: the frequency, time of onset, severity, and duration. MedStar authors:
  • Acio, Elmo
  • Burman, Kenneth D
  • Garcia, Carlos
  • Khorjekar, Gauri R
  • Kulkarni, Kanchan
  • Orquiza, Michael H
  • Schneider, M
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Department:
  • Medicine/Endocrinology
  • Medicine/General Internal Medicine
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D
Local accession number:
  • 2014.1_133
13.
Altered taste after 131I therapy: the frequency, time of onset, severity, and duration MedStar authors:
  • Acio, Elmo
  • Burman, Kenneth D
  • Garcia, Carlos
  • Khorjekar, Gauri R
  • Kulkarni, Kanchan
  • Orquiza, Michael H
  • Schneider, M
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Department:
  • Medicine/Endocrinology
  • Medicine/General Internal Medicine
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L,Van Nostrand D
Local accession number:
  • 2014.1_134
Pages

Powered by Koha